Analyst Price Targets — LWAY
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 14, 2026 2:25 pm | — | Morgan Stanley | $35.00 | $21.95 | StreetInsider | Benchmark Reiterates Buy Rating on Lifeway Foods (LWAY) |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for LWAY

Leading kefir brand's high protein cottage cheese alternative MORTON GROVE, Ill., June 29, 2026 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or the "Company"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, announced today that its Farmer Cheese was named a winner in Good Housekeeping's 2026 Snack Awards.

An immersive pop-up experience invites guests to discover the delicious possibilities of Lifeway Kefir through custom smoothies, exclusive merchandise and special surprises An exclusive first look at The Lifeway Kefir Shop will feature soccer star Rose Lavelle, music by AMRIT, plus a live performance by Cannons MORTON GROVE, Ill., June 15, 2026 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the…

EDWARD SMOLYANSKY, KEY LWAY SHAREHOLDER: TERMINATION OF POISON PILL MARKS IMPORTANT INFLECTION POINT FOR LIFEWAY SHAREHOLDERS AS GOVERNANCE QUE

CHICAGO, June 8, 2026 /PRNewswire/ -- Edward Smolyansky, former Director and Chief Operating Officer of Lifeway Foods, Inc. (NASDAQ: LWAY) and the Company's largest shareholder, today issued the following statement regarding Lifeway's decision to terminate its shareholder rights plan. "Lifeway has finally terminated the poison pill, only after ISS recommended AGAINST the whole Board.

Lifeway (LWAY) delivered 37% organic revenue growth and margin expansion in Q1 2026, exceeding analyst expectations. Danone's complete exit via a secondary offering introduces short-term headwinds, but LWAY's recent acceleration appears independent of Danone. With 26 consecutive quarters of growth, no debt, and new fitness-focused products, LWAY remains well-positioned for continued expansion.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LWAY.
U.S. House Trading
No House trades found for LWAY.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
